Growth hormone and estrogen pharmacogenetics in patients with Turner Syndrome
Analysis of polymorphisms CT60 of CTLA4 gene and -1623A/G in the promoter region o...
Analysis of polymorphisms CT60 of CTLA4 gene and-1623A/G in the promoter region of...
Screening of variants of unkown significance (VUS) in the RET proto-oncogene in p...
Screening of variants of unkown significance (VUS) in the RET proto-oncogene in pa...
Determination of risk factors for cardiovascular disease in Turner Syndrome patien...
Methylenetetrahydrofolate Reductase (MTHFR) polymorphisms as a risk factor for Tur...